title: Cognitive control and the dopamine D₂-like receptor: a dimensional understanding of addiction.
abstract: The phenotypic complexity of psychiatric conditions is revealed by the dimensional nature of these disorders, which consist of multiple behavioral, affective, and cognitive dysfunctions that can result in substantial psychosocial impairment. The high degree of heterogeneity in symptomatology and comorbidity suggests that simple categorical diagnoses of "affected" or "unaffected" may fail to capture the true characteristics of the disorder in a manner relevant to individualized treatment. A particular dimension of interest is cognitive control ability because impairments in the capacity to control thoughts, feelings, and actions are key to several psychiatric disorders. Here, we describe evidence suggesting that cognitive control over behavior is a crucial dimension of function relevant to addictions. Moreover, dopamine (DA) D(2)-receptor transmission is increasingly being identified as a point of convergence for these behavioral and cognitive processes. Consequently, we argue that measures of cognitive control and D(2) DA receptor function may be particularly informative markers of individual function and treatment response in addictions.
authors.affiliation: Department of Psychology, University of California, Los Angeles, California 90095-1563, USA.
authors.forename: Stephanie M
authors.initials: SM
authors.lastname: Groman
authors.forename: J David
authors.initials: JD
authors.lastname: Jentsch
mesh_terms: D016739:Behavior, Addictive / Q000378:metabolism* / Q000503:physiopathology; D015415:Biomarkers; D004298:Dopamine / Q000502:physiology*; D006801:Humans; D007175:Impulsive Behavior / Q000378:metabolism / Q000503:physiopathology; D007266:Inhibition, Psychological; D001523:Mental Disorders / Q000378:metabolism* / Q000503:physiopathology; D017448:Receptors, Dopamine D2 / Q000502:physiology*
chemical_list: D015415:Biomarkers; D017448:Receptors, Dopamine D2; D004298:Dopamine